Holen Sie sich die Stockscreener-App
0.4073
9.49%
-0.0427
Schlusskurs vom Vortag:
$0.45
Offen:
$0.441
24-Stunden-Volumen:
51,735
Relative Volume:
0.54
Marktkapitalisierung:
$2.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.66M
KGV:
-0.6787
EPS:
-0.6001
Netto-Cashflow:
$-2.83M
1W Leistung:
-13.10%
1M Leistung:
-6.35%
6M Leistung:
-50.71%
1J Leistung:
-57.13%
1-Tages-Spanne:
$0.3635
$0.441
1-Wochen-Bereich:
$0.3635
$0.487
52-Wochen-Spanne:
$0.3635
$1.41
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Firmenname
Xortx Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.4082 | 3.13M | 0 | -2.66M | -2.83M | -0.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.22 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.63 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.02 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.96 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.43 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xortx Therapeutics Inc Aktie (XRTX) Neueste Nachrichten
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation - Bitget
XORTX Brief: Reporting that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" Share Consolidation - marketscreener.com
XORTX Reports that Independent Proxy Advisory Firms - GlobeNewswire
Whats the RSI of XORTX Therapeutics Inc stockMarket Growth Report & Daily Profit Focused Stock Screening - baoquankhu1.vn
XORTX Therapeutics looks to raise $3M through private placement - MSN
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders - Bitget
XORTX Therapeutics Completes Filing and Mailing of Documents for Annual and Special Shareholder Meeting - geneonline.com
XORTX seeks shareholder vote on up to 5-for-1 share consolidation - Stock Titan
XORTX Announces Filing and Mailing of the Meeting Documents - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
XORTX (NASDAQ: XRTX) seeks share consolidation to meet $1 bid - Stock Titan
XRTX Should I Buy - Intellectia AI
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XORTX Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
XRTXXortx Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Sectors Review: Can XORTX Therapeutics Inc continue delivering strong returnsJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
What’s the beta of XORTX Therapeutics Inc. stockJuly 2025 Selloffs & Weekly High Return Opportunities - mfd.ru
Take Profit: What is the target price for XORTX Therapeutics Inc stock2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
XRTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can XORTX Therapeutics Inc. continue delivering strong returnsDay Trade & Reliable Price Action Trade Plans - mfd.ru
Is XORTX Therapeutics Inc. stock a buy before product launchesEarnings Performance Report & Smart Swing Trading Techniques - mfd.ru
Will XORTX Therapeutics Inc. outperform during market ralliesWeekly Stock Report & Growth Oriented Trade Recommendations - mfd.ru
Trading Action: What is XORTX Therapeutics Incs TAM Total Addressable MarketMarket Performance Recap & Verified Technical Signals - baoquankhu1.vn
XORTX Therapeutics Brief: Provided Overnight Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - marketscreener.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars - Nasdaq
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - markets.businessinsider.com
Kidney drug deal: XORTX gets more time to close Vectus buy - Stock Titan
XORTX (NASDAQ: XRTX) extends VB4-P5 kidney fibrosis deal deadline - Stock Titan
Investor Mood: Why is OSBC stock going upRate Cut & Real-Time Price Movement Reports - baoquankhu1.vn
Travel Stocks: Whats the RSI of XORTX Therapeutics Inc stock2025 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
EPS Watch: Can XORTX Therapeutics Inc continue delivering strong returns - baoquankhu1.vn
Is XORTX Therapeutics Inc. a speculative investment2025 Market WrapUp & Weekly Consistent Profit Watchlists - mfd.ru
Does XORTX Therapeutics Inc. meet Warren Buffett’s criteriaWeekly Trend Report & Short-Term Trading Opportunity Alerts - mfd.ru
Earnings Miss: What is the target price for XORTX Therapeutics Inc stockInflation Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Treasury Yields: Does XORTX Therapeutics Inc meet Warren Buffetts criteriaJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Market Fear: What is XORTX Therapeutics Incs TAM Total Addressable MarketJuly 2025 Momentum & AI Optimized Trade Strategies - baoquankhu1.vn
XORTX leans into genetic breakthroughs in gout as it reshapes board and advances oxypurinol - MSN
Dividend Watch: Is XORTX Therapeutics Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Sentiment Recap: How XORTX Therapeutics Inc stock performs after earningsWeekly Trade Review & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Is XORTX Therapeutics Inc. stock positioned well for digital economyOil Prices & Weekly Setup with ROI Potential - Улправда
Revenue per share of XORTX Therapeutics Inc. – NASDAQ:XRTX - TradingView — Track All Markets
Why XORTX Therapeutics Inc. stock remains resilientJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
Is XORTX Therapeutics Inc. (ANUA) stock a buy before earnings resultsQuarterly Trade Review & Weekly Top Stock Performers List - ulpravda.ru
Will XORTX Therapeutics Inc. stock attract more institutional investors2025 Risk Factors & Long Hold Capital Preservation Tips - ulpravda.ru
Contact | Statesman-ExaminerXORTX Therapeutics Inc.Common Stock (Nasdaq:XRTX) Stock Quote - FinancialContent
XORTX Therapeutics : Investor Presentation - MarketScreener
Will XORTX Therapeutics Inc. stock beat EPS estimatesStock Split Announcements & High Profit Portfolio Growth - Улправда
Published on: 2026-01-07 21:30:14 - Улправда
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing - MSN
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol - TipRanks
Finanzdaten der Xortx Therapeutics Inc-Aktie (XRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):